All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY932 | Anti-TRIM28 (23/KRIP1) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat, Dog, Human, Mouse | 23/KRIP1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2572 | Anti-TRIM28(23/KRIP1) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat, Dog, Human, Mouse | 23/KRIP1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ365 | Anti-TRIM28 (20A1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 20A1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ366 | Anti-TRIM28 (TRI5I093) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse | TRI5I093 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ367 | Anti-TRIM28 (1D11) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 1D11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ368 | Anti-TRIM28 (4E6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 4E6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ865 | Anti-TRIM28 (20A1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 20A1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ866 | Anti-TRIM28 (TRI5I093) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse | TRI5I093 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ867 | Anti-TRIM28 (1D11) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 1D11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ868 | Anti-TRIM28 (4E6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 4E6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION